Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08PLR
|
||||
Former ID |
DIB006552
|
||||
Drug Name |
Trelagliptin Succinate
|
||||
Synonyms |
DPP-IV inhibitors (oral, type II diabetes); DPP-IV inhibitors (oral, type II diabetes), Takeda
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Non-insulin dependent diabetes [ICD10:E11.9] | Investigative | [543447] | ||
Company |
Takeda Pharmaceutical Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H26FN5O6
|
||||
Canonical SMILES |
FC(F)(C(=O)O)F.C(#N)c1c(cc(cc1)F)Cn1c(=O)n(c(=O)cc1N1C[<br />C@@H](CCC1)N)C
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [543447] | |
KEGG Pathway | Protein digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.